Overview
- 58 inspections across 57 sites are on record.
- 4 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2018-09-12.
At a glance
Inspections
58
Sites
57
Observations
4
Career since
Jun 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Octapharma Plasma Inc | 12 Sep 2018 | Biologics | |
| ADMA BioCenters Georgia Inc. | 16 Aug 2018 | Biologics | |
| Octapharma Plasma, Inc. | 10 Jul 2018 | Biologics | |
| Biomat USA, Inc. | 23 May 2018 | Biologics | |
| Octapharma Plasma Inc | 21 Mar 2018 | Biologics |
Sites inspected
Octapharma Plasma IncFife, United States1 insp.
ADMA BioCenters Georgia Inc.Marietta, United States1 insp.
Octapharma Plasma, Inc.Vancouver, United States1 insp.
Biomat USA, Inc.Opelika, United States1 insp.
Octapharma Plasma IncOklahoma City, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Marion W Nadeau4 shared
Kathleen B Swat3 shared
Mary I Surratt3 shared
Verdell Nelson3 shared
Jaime E Perry2 shared
Kanaeko R Ravenell2 shared
Decarlos A Gomez2 shared
Vanessa Y Jacobs2 shared
Barbara T Carmichael2 shared
Dana M Klimavicz2 shared
Full investigator report
Get the verbatim findings behind Diane Hall's 4 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site